Neurological
Cancer

Oncology Solutions

In the United States, about 23,820 malignant tumors of the brain or spinal cord will be diagnosed in 2019.1 With the technological advances in the technology field, brain tumor imaging has become an essential component in managing the patients across the care pathway.


The Patient Journey

  • Early Detection

    SIGNA™ Artist AIR™ Edition

    Our premium 1.5T, 70 cm wide bore MRI system leverages intelligent technology to enable patient-friendly exams with exceptional image quality.

  • Diagnosis

    SIGNA™ Architect AIR™ Edition

    Our premium 3.0T, 70 cm wide bore MRI system leverages intelligent technology to enable patient-friendly exams with exceptional image quality.
  • Staging

    SIGNA™ Premier AIR™ Edition

    Our leading, innovative 3.0T MRI system brings you uncompromised 60 cm performance in a 70 cm wide bore for advanced imaging and research.
  • Treatment Planning

    MR Radiation Oncology Suite

    Our MR Radiation Oncology Suite provides the tools designed to help you better target and treat tumors through consistent patient positioning.
  • Therapy and Monitoring

    PET VCAR

    Comprehensive PET oncology analysis solution with multi-modality and multi-time metabolic and anatomic evolution comparison.
  • Follow up

    SIGNA™ PET/MR with QuantWorks

    Our fully integrated PET/MR system combines TOF, quantitative accuracy and high sensitivity with our innovative Q.Clear reconstruction.

The latest in Oncology


1. https://www.cancer.org/cancer/brain-spinal-cord-tumors-adults/about/key-statistics.html